GSK projects 2-million-dose flu vaccine shortfall for Canada
GSK, Canada's largest flu vaccine supplier, said today it won't be able to fill about 30% of its Canadian order for the upcoming flu season because of problems at its Ste. Foy, Que., plant, the Canadian Press reported today.
It's unclear how the deficit will affect GSK doses in the United States, a GSK spokesman told CIDRAP News.